Fine‐mapping and replication of EWAS loci harboring putative epigenetic alterations associated with AD neuropathology in a large collection of human brain tissue samples

Our previous epigenome‐wide association study (EWAS) of Alzheimer's disease (AD) in human brain identified 71 CpGs associated with AD pathology. However, due to low coverage of the Illumina platform, many important CpGs might have been missed.

[1]  Benjamin A. Logsdon,et al.  Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue , 2021, Nature Communications.

[2]  D. Bennett,et al.  Human Brain and Blood N-Glycome Profiling in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias , 2021, Frontiers in Aging Neuroscience.

[3]  C. Jack,et al.  Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[4]  W. M. van der Flier,et al.  Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores , 2021, Nature Communications.

[5]  Daniel J. Gaffney,et al.  Genome-wide meta-analysis, fine-mapping, and integrative prioritization implicate new Alzheimer’s disease risk genes , 2021, Nature Genetics.

[6]  Chunshui Yu,et al.  Hippocampal transcriptome-wide association study and neurobiological pathway analysis for Alzheimer’s disease , 2021, PLoS genetics.

[7]  Weiqi Chen,et al.  Glycemic traits and Alzheimer’s disease: a Mendelian randomization study , 2020, Aging.

[8]  Nick C Fox,et al.  New insights on the genetic etiology of Alzheimer’s and related dementia , 2020 .

[9]  Charles C. White,et al.  Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer’s disease , 2020, bioRxiv.

[10]  Naaheed Mukadam,et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission , 2020, The Lancet.

[11]  Stephen C. J. Parker,et al.  The Trans-Ancestral Genomic Architecture of Glycemic Traits , 2020, Nature Genetics.

[12]  Benjamin A. Logsdon,et al.  Multi-tissue neocortical transcriptome-wide association study implicates 8 genes across 6 genomic loci in Alzheimer’s disease , 2020, Genome Medicine.

[13]  Alan J. Thomas,et al.  A meta-analysis of epigenome-wide association studies in Alzheimer’s disease highlights novel differentially methylated loci across cortex , 2020, Nature Communications.

[14]  M. Bozzali,et al.  Cerebello-Cortical Alterations Linked to Cognitive and Social Problems in Patients With Spastic Paraplegia Type 7: A Preliminary Study , 2020, Frontiers in Neurology.

[15]  E. Colicino,et al.  DNA Methylation–Based Biomarkers of Environmental Exposures for Human Population Studies , 2020, Current Environmental Health Reports.

[16]  James B. Brewer,et al.  Brain cell type–specific enhancer–promoter interactome maps and disease-risk association , 2019, Science.

[17]  P. Barbarino,et al.  THE STATE OF THE ART OF DEMENTIA RESEARCH: NEW FRONTIERS , 2019, Alzheimer's & Dementia.

[18]  Trevor Hastie,et al.  Genetics of 35 blood and urine biomarkers in the UK Biobank , 2020, Nature Genetics.

[19]  Arturas Petronis,et al.  Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms , 2019, Nature Communications.

[20]  V. Vaccarino,et al.  DNA Methylation of Five Core Circadian Genes Jointly Contributes to Glucose Metabolism: A Gene-Set Analysis in Monozygotic Twins , 2019, Front. Genet..

[21]  Nick C Fox,et al.  Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.

[22]  J. Mill,et al.  A cross-brain regions study of ANK1 DNA methylation in different neurodegenerative diseases , 2019, Neurobiology of Aging.

[23]  Anne E Carpenter,et al.  BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 implicated in Tau pathology , 2019, bioRxiv.

[24]  Timothy J. Hohman,et al.  Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk , 2019, Nature Genetics.

[25]  Bin Zhang,et al.  Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer’s disease susceptibility , 2018, Nature Genetics.

[26]  Jun Xie,et al.  Cauchy Combination Test: A Powerful Test With Analytic p-Value Calculation Under Arbitrary Dependency Structures , 2018, Journal of the American Statistical Association.

[27]  F. Piferrer,et al.  Consistent inverse correlation between DNA methylation of the first intron and gene expression across tissues and species , 2018, Epigenetics & Chromatin.

[28]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[29]  U. Muthane,et al.  Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile Parkinsonism , 2016, Journal of Medical Genetics.

[30]  D. Bennett,et al.  Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease , 2014, Nature Neuroscience.

[31]  Manolis Kellis,et al.  Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014 .

[32]  Manolis Kellis,et al.  Alzheimery's disease pathology is associated with early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014, Nature Neuroscience.

[33]  Francis Eustache,et al.  Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease , 2013, NeuroImage: Clinical.

[34]  J. Schneider,et al.  Overview and findings from the religious orders study. , 2012, Current Alzheimer research.

[35]  J. Schneider,et al.  Overview and findings from the rush Memory and Aging Project. , 2012, Current Alzheimer research.

[36]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[37]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .

[38]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[39]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[40]  N. Maglaveras,et al.  Human epigenome data reveal increased CpG methylation in alternatively spliced sites and putative exonic splicing enhancers. , 2011, DNA and cell biology.

[41]  E. Soriano,et al.  Podocalyxin Is a Novel Polysialylated Neural Adhesion Protein with Multiple Roles in Neural Development and Synapse Formation , 2010, PloS one.

[42]  J. Nielsen,et al.  The role of podocalyxin in health and disease. , 2009, Journal of the American Society of Nephrology : JASN.

[43]  N. Bresolin,et al.  A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia , 2008, Human mutation.

[44]  Sergio Cocozza,et al.  Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease , 1998, Cell.